Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Omega Healthcare Investors Inc    OHI

OMEGA HEALTHCARE INVESTORS INC (OHI)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 09/21 04:24:19 pm
32.915 USD   +0.32%
08/14OMEGA HEALTHCAR : Orianna Health Systems, LLC
AQ
08/03OMEGA HEALTHCAR : 2Q Earnings Snapshot
AQ
08/03OMEGA HEALTHCAR : Announces Second Quarter 2018 Financial Results
BU
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Omega Healthcare Investors Inc : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Omega Healthcare Investors, Inc. of Class Action Lawsuit and Upcoming Deadline - OHI

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2018 | 02:26pm CEST

NEW YORK, NY / ACCESSWIRE / January 13, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Omega Healthcare Investors, Inc. ("Omega" or the "Company") (NYSE: OHI) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 17-cv-09024, is on behalf of a class consisting of investors who purchased or otherwise acquired Omega securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Omega securities between February 8, 2017, and October 31, 2017, both dates inclusive, you have until January 16, 2018, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and amount of shares purchased.

[Click here to join this class action]

Omega is a self-administered real estate investment trust ("REIT") that invests in income producing healthcare facilities, including long-term care facilities located in the United States and the United Kingdom.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) financial and operating results of certain of the Company's operators were deteriorating; (ii) as a result, certain of the Company's operators were experiencing worsening liquidity issues that were significantly impacting the operators' ability to make timely rent payments; (iii) as a result, certain of the Company's direct financing leases were impaired and certain receivables were uncollectible; and (iv) as a result of the foregoing, Defendants' statements about Omega's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

On July 26, 2017, after the market closed, the Company issued a press release entitled, "Omega Announces Second Quarter 2017 Financial Results; Increased Dividend Rate for 20th Consecutive Quarter."

On the next day, July 27, 2017, the Company held a conference call to discuss its second quarter results. On this news, the Company's stock price fell $1.35 per share, or 4%, to close at $32.10 per share on July 27, 2017, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


© Accesswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OMEGA HEALTHCARE INVESTORS
08/14OMEGA HEALTHCARE INVESTORS : Orianna Health Systems, LLC
AQ
08/06OMEGA HEALTHCARE INVESTORS INC : Omega Healthcare Investors, Inc. to Host Earnin..
AC
08/03OMEGA HEALTHCARE INVESTORS INC : Results of Operations and Financial Condition, ..
AQ
08/03OMEGA HEALTHCARE INVESTORS : 2Q Earnings Snapshot
AQ
08/03OMEGA HEALTHCARE INVESTORS : Announces Second Quarter 2018 Financial Results
BU
07/30OMEGA HEALTHCARE INVESTORS INC : Ex-dividend day for
FA
07/27OMEGA HEALTHCARE INVESTORS INC : Ex-Dividend Alert: Omega Healthcare Investors H..
AC
07/23OMEGA HEALTHCARE INVESTORS : Terminates Restructuring Support Agreement; Range o..
BU
07/13OMEGA HEALTHCARE INVESTORS : Announces Quarterly Common Stock Dividend and Sched..
BU
07/13Free Research Reports on Physicians Realty Trust and Three More REIT Stocks
AC
More news
News from SeekingAlpha
09/20HEALTHCARE REITS : Demographic Boom Within Sight 
09/19Getting Paid 8% To Ride The 'Silver Tsunami' 
09/17MY ANNIVERSARY : One Year Later, My Articles Outperform The S&P By 50% 
09/14OMEGA HEALTHCARE : Ignore Fundamentals At Your Own Risk 
09/13Is The Dividend Of Omega Healthcare Investors Safe? 
Financials ($)
Sales 2018 878 M
EBIT 2018 504 M
Net income 2018 326 M
Debt 2018 4 441 M
Yield 2018 8,05%
P/E ratio 2018 20,92
P/E ratio 2019 20,25
EV / Sales 2018 12,5x
EV / Sales 2019 12,1x
Capitalization 6 573 M
Chart OMEGA HEALTHCARE INVESTORS INC
Duration : Period :
Omega Healthcare Investors Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMEGA HEALTHCARE INVESTORS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 30,8 $
Spread / Average Target -6,3%
EPS Revisions
Managers
NameTitle
Taylor C. Pickett Chief Executive Officer & Director
Craig R. Callen Chairman
Daniel J. Booth Chief Operating Officer
Robert O. Stephenson Chief Financial Officer & Treasurer
Bernard J. Korman Director
Sector and Competitors
1st jan.Capitalization (M$)
OMEGA HEALTHCARE INVESTORS INC19.14%6 573
WELLTOWER INC2.82%24 394
VENTAS-5.07%20 306
HCP1.04%12 380
HEALTHCARE TRUST OF AMERICA INC-10.89%5 570
MEDICAL PROPERTIES TRUST, INC.5.44%5 367